MD Biosciences

Products and preclinical contract research (CRO) for inflammation, neurology, cardiovascular and pain. Our approach is one of complete flexibility. Test items can be evaluated as a strategic and systematic process or as a stand alone service depending on where in the development phase a test item is. MD Biosciences staff can operate as an external research group for the client, capable of initiating ideas, proposing projects, bringing insight and observations We provide a customized, efficient and systematic approach to discovery aimed at reducing late phase failures.


Services capabilities:
- in vitro screening for compound profiling studies
- in vivo and in vitro mechanism of action platforms for therapeutic targeting or repositioning strategies
- Efficacy and proof-of-concept studies
- Biomarker and gene expression analysis
- Imaging capabilities
- Histology and IHC analysis

Products include:
- Disease induction reagents
- ELISA and assay kits
- Proteins and Antibodies